Ophthalmology · Glendale, CA
NPI
1467541508
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1111 N Brand Blvd Ste 320
Glendale, CA, 91202
Phone (818) 552-2140
Groups this clinician bills Medicare through
Medicare paid, 2024
$778K
6,207 services
Medicare patients, 2024
646
Average age 77
Drug cost, 2024
$436K
2,584 prescriptions
Company payments, 2025
$652
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marta A Recasens was code 92134 (computerized ophthalmic imaging), 1,811 times for 629 patients. In total Marta A Recasens billed 6,207 services in 38 codes, and Medicare paid $778K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92134 Computerized Ophthalmic Imaging | Office | 1,811 | 629 | $32.33 | $59K |
| 92014 Ophthalmological E&M | Office | 965 | 516 | $94.18 | $91K |
| 92012 Ophthalmological E&M | Office | 876 | 268 | $71.36 | $63K |
| J0178 Injection, aflibercept, 1 mg | Office | 608 | 78 | $659.07 | $401K |
| 67028 Intravitreal Injection | Office | 587 | 132 | $92.42 | $54K |
| 92202 Ophthalmological E&M | Office | 290 | 202 | $11.23 | $3,256 |
| J9035 Injection, bevacizumab, 10 mg | Office | 231 | 62 | $56.53 | $13K |
| 99204 Office E&M - New | Office | 124 | 124 | $117.71 | $15K |
| 92201 Ophthalmological E&M | Office | 109 | 109 | $17.95 | $1,956 |
| 92083 Vision, Hearing, and Speech Services | Office | 77 | 72 | $54.20 | $4,173 |
| 92133 Computerized Ophthalmic Imaging | Office | 76 | 71 | $28.12 | $2,137 |
| 67820 Eye | Office | 27 | 17 | $15.92 | $430 |
By year: 2022 $753K for 6,312 services; 2023 $782K for 6,040 services; 2024 $778K for 6,207 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marta A Recasens prescribed most often to Medicare patients was Latanoprost, with 334 prescriptions and refills. In total Marta A Recasens wrote 2,584 Medicare prescriptions that cost $436K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 334 | 467 | 58 | $2,811 |
| Ketorolac Tromethamine Generic | 252 | 335 | 62 | $7,417 |
| Brimonidine Tartrate Generic | 180 | 249 | 37 | $12K |
| Lumigan Bimatoprost | 178 | 205 | 30 | $54K |
| Prolensa Bromfenac Sodium | 142 | 168 | 29 | $49K |
| Cyclosporine Generic | 139 | 149 | 28 | $45K |
| Prednisolone Acetate Generic | 118 | 143 | 46 | $3,829 |
| Fluorometholone Generic | 99 | 116 | 31 | $6,044 |
| Alphagan P Brimonidine Tartrate | 91 | 109 | 18 | $24K |
| Restasis Cyclosporine | 83 | 94 | 19 | $59K |
| Simbrinza Brinzolamide/Brimonidine Tart | 79 | 95 | 11 | $16K |
| Dorzolamide Hcl Generic | 79 | 133 | 27 | $1,014 |
| Combigan Brimonidine Tartrate/Timolol | 78 | 89 | 13 | $18K |
| Timolol Maleate Generic | 68 | 109 | 14 | $651 |
| Tobradex St Tobramycin/Dexamethasone | 53 | 60 | 24 | $13K |
Brand drugs: 1,561 claims; generic drugs: 1,023 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marta A Recasens $652 ($652 in general payments such as food, travel and fees) from 5 companies. The largest payer was Astellas Pharma US Inc with $250.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.